本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

和黄医药

15.35
+0.09000.59%
盘后15.350.00000.00%16:04 EDT
成交量:6.06万
成交额:92.75万
市值:26.25亿
市盈率:76.75
高:15.43
开:15.26
低:15.02
收:15.26
数据加载中...
2025/03/19

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/28

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/08/24

SEC问询函

Form CORRESP - Correspondence
2023/02/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/07/25

SEC问询函

CORRESP [Cover] - Correspondence
2022/06/08

SEC问询函

CORRESP [Cover] - Correspondence
2022/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/30

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/04/13

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/04

财报披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/04

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/07/30

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/07/07

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership